Quality of life measurement in pancreatic cancer patients : a randomized trial of percutaneous splanchnic nerve neurolysis versus endoscopic ultrasound guide celiac plexus neurolysis

Phase 1

• Conditions: pancreatic cancer patient with abdominal pain.; pancreatic cancer, cancer pain, splanchnic nerve neurolysis, neurolysis, celiac plexus neurolysis, abdominal pain

• Registration Number: TCTR20220512002
• Lead Sponsor: Ratchadapisek Research Funds

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-05-12
• Study Completion: 2023-06-01
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: nknown
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

1. age above 18 years
2. Pancreatic cancer patient with numeric rating scale more than 4 from total 10 score
3.patient can make decision to apply the study by themselves and cooperate with the protocol
4.Patient who can follow up for 1 month after procedure

Exclusion Criteria

1. Allergic to agent in study
2.Refuse to join study
3. gut obstruction
3.coagulopathy or use antiplatelet or anticoagulant drug that can not control bleeding risk
4.Pregnancy
5.uncontrol underlying disease sush as uncontrol hypertension, heart failure
6.uncommunicative patient
7.severe systemic infection, local infection in procedure area
8.patient who have pain in other area except abdominal pain
9.Previous percutaneous splanchnic nerve neurolysis or endoscopic ultrasound guide celiac plexus neurolysis

Study & Design

• Study Type: Interventional
• Study Design: Not specified